Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000517471) titled 'Optimising identification and management of hypoglycaemia in hospital i... Read More
Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000507482) titled 'A hybrid implementation and effectiveness trial to assess the effective... Read More
Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ISRCTN86866399) titled 'Impact of a novel post-discharge clinic on post-hospital follow-up among Vet... Read More
Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ISRCTN11572715) titled 'Frailty and sarcopenia experience in persons with Parkinson's disease' on Ma... Read More
Geneva, June 4 -- International Clinical Trials Registry received information related to the study (TCTR20250523003) titled 'Situation on type 2 diabetes mellitus in Sakon Nakhon province: A study on ... Read More
Geneva, June 4 -- International Clinical Trials Registry received information related to the study (TCTR20250523001) titled 'Development of Preventing Suicide Model among Older Adults in Community Bas... Read More
Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000496415) titled 'Selecting patients for sleep surgery using novel physiological and surg... Read More
Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000506493) titled 'A direct comparison of angiotensin vs. noradrenaline therapy for the ma... Read More
Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ISRCTN43589298) titled 'Prevalence of burnout syndrome among resident physicians in Syria: a cross-s... Read More
Geneva, June 4 -- International Clinical Trials Registry received information related to the study (EUCTR2025-000201-16-Outside-EU/EEA) titled 'A phase II open-label, multiple dose study to assess the... Read More